US Broker Ratings

Globus Medical, Inc. (GMED): Analyst Ratings Suggest a 36.28% Upside for Investors

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. The company,..

Genmab A/S (GMAB) Stock Analysis: Uncovering a 31% Potential Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) presents a compelling case. Headquartered in Copenhagen, Denmark, this biotech powerhouse has carved a..

Regencell Bioscience Holdings (RGC): A Unique Play in Healthcare with Intriguing Technicals

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands as a distinctive entity in the healthcare sector, operating within the niche of Traditional Chinese Medicine (TCM) for neurocognitive..

Elanco Animal Health (ELAN): Stock Analysis Shows Modest Upside Amidst Strong Product Portfolio

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with a 44% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a significant player in the biotechnology sector, presenting intriguing prospects for investors. Based in Morrisville, North Carolina, the..

Alkermes plc (ALKS) Investor Outlook: Strong Buy Ratings and 42.86% Upside Potential Highlight Growth Prospects

Alkermes plc (NASDAQ: ALKS), a Dublin-based biopharmaceutical company, is capturing the attention of investors with its robust product lineup and promising growth potential. Specializing in the..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Robust Revenue Growth Amidst High Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a dynamic player within the biotechnology sector, is making waves with its focus on developing innovative therapies for central nervous system..

Haleon plc (HLN) Stock Analysis: Exploring a 20% Upside Potential in a Stable Healthcare Giant

Haleon plc (HLN) stands as a formidable player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industry. With a robust market capitalization..

Alcon Inc. (ALC) Stock Analysis: Navigating a 19.91% Potential Upside in Healthcare

Alcon Inc. (NYSE: ALC), a global leader in eye care headquartered in Geneva, Switzerland, stands as a prominent player in the healthcare sector, specifically within the..

Ionis Pharmaceuticals (IONS) Stock Analysis: Unlocking a 33% Potential Upside in RNA-Targeted Medicines

Ionis Pharmaceuticals, Inc. (IONS), a leading player in the biotechnology sector, is gaining investor attention with its promising pipeline of RNA-targeted medicines. As a commercial-stage biotechnology..

Masimo Corporation (MASI) Investor Outlook: Analysts Signal a 21.90% Potential Upside

Masimo Corporation (MASI), a prominent player in the healthcare sector, specializes in medical devices that are revolutionizing patient monitoring and automation solutions worldwide. With a market..

Stryker Corporation (SYK) Stock Analysis: Unlocking a 13% Upside Potential with Strong Buy Ratings

Stryker Corporation (NYSE: SYK), a prominent player in the healthcare sector, specifically in the medical devices industry, is capturing the attention of investors with its robust..

ICON plc (ICLR) Stock Analysis: A 24% Upside Potential Beckons in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find ICON plc (NASDAQ: ICLR) a compelling prospect. This Ireland-based clinical research organization, with a market capitalization of..

Viatris Inc. (VTRS) Stock Analysis: Evaluating a Potential 7.72% Upside in the Healthcare Sector

Viatris Inc. (NASDAQ: VTRS) stands as a prominent player in the global healthcare sector, providing a diverse range of pharmaceutical products. As a company with a..

Blueprint Medicines Corporation (BPMC): Investor Outlook Amid Strong Revenue Growth and Technical Opportunities

Blueprint Medicines Corporation (BPMC) is carving a niche in the biotechnology sector with its focus on precision therapy for genomically defined cancers and blood disorders. With..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 22.77% Potential Upside Amid Strong Revenue Growth

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable entity within the biotechnology sector, with a robust market capitalization of $100.71 billion. The company’s core focus..

Nuvalent, Inc. (NUVL) Stock Analysis: Biotech Innovator Offers a Potential 52.91% Upside

Nuvalent, Inc. (NASDAQ: NUVL), a pioneering entity in the biotechnology sector, is carving a niche with its cutting-edge cancer therapies. As a clinical-stage biopharmaceutical company, Nuvalent..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 19.28% Potential Upside for Investors

In the dynamic world of healthcare technology, Koninklijke Philips N.V. (NYSE: PHG) stands out with its robust presence across the globe. Headquartered in Amsterdam, this Dutch..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with 69.65% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, is capturing investor attention with a compelling potential upside of 69.65%. The company, headquartered..

Boston Scientific Corporation (BSX) Stock Analysis: Strong Buy Ratings Signal 20% Upside Potential

Boston Scientific Corporation (NYSE: BSX), a formidable player in the healthcare sector, continues to capture investor attention with its innovative medical devices and promising growth trajectory...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds